Screener / SEC EDGAR /CIK 0001295947 /10-K filed May 14, 2026, compared with May 9, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Prestige Consumer Healthcare Inc. PBH

Compare with peers Embed
SEC comment letters, last 20 years

8 reviews of PBH's filings by SEC staff

UPLOAD and CORRESP
Reviews 8 latest letter Mar 1, 2016
Questions asked 30 each answered in the company's own letter
No closing letter 4 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 10 UPLOAD
  2. 2. Questions in them 30 numbered comments
  3. 3. Company replies 8 CORRESP
  4. 4. Reviews closed 4 of 8 closing letter

Half the closed reviews took 61 days or less from the first letter to the closing letter.

Form 10-K

2016-03-01 to 2016-03-04 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2016-03-04
Executive pay
Item 11. Executive Compensation, page 115
SEC asked
We note that you do not include the information required by Items 402(b) and 407(e)(4) and (e)(5) of Regulation S-K or incorporate such information by reference to your definitive proxy statement. Please confirm that you will provide such information in future filings or incorporate such information by reference to your definitive proxy statement as required by Part III, Item 11 of Form 10-K.
PBH answered
The Company hereby confirms that it will specifically incorporate by reference the information required by Items 402(b) and 407(e)(4) and (e)(5) of Regulation S-K to our definitive proxy statement as required by Part III, Item 11 of Form 10-K.

The Registrant hereby acknowledges that:

l the company is responsible for the adequacy and accuracy of the disclosure in the filing;

staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and the company may not assert staff comments as a defense in any
Rest of the answer

proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We trust that this has been responsive to the Staff's comment. If there are additional questions or comments, please contact the undersigned at (914) 524-6882.

Read in the reply
In its next report

First report after the company's reply of Mar 3, 2016: 10-K filed May 17, 2016 ↗, against the 10-K filed May 14, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2016-03-04

Form 10-K for the Fiscal Year Ended March 31, 2012

2013-02-27 to 2013-05-06 · 7 questions · 2 letters from the SEC, 2 from the company
Review closed 2013-05-06
DebtResults discussion (MD&A)RevenueAcquisitionsLiquidity and cash
Note 1. Business and Basis of Presentation · Revenue Recognition, page 61
SEC asked (1)
Please provide us proposed disclosure to be included in future filings to clarify how you account for your promotional programs in the financial statements, other than slotting fees. Tell us the specific accounting literature you are using to support your accounting treatment.
PBH answered
We provide trade allowances, which include cooperative advertising, temporary price reductions, slotting fees and coupons, to our customers and consumers and accrue for such incentives at the date the related revenue is recognized or, if later, the date at which the sales incentive is offered, in accordance with ASC 605-50-25. We typically do not offer significant rebates and volume incentives.
Rest of the answer

Cooperative advertising, including various promotional programs, temporary price reductions, coupons and slotting fees, are offered to customers as incentives to increase their marketing efforts and promote sales of our products. Our accounting policy for these payments (allowances) to our customers requires these transactions to be recorded as revenue reductions at the time of sale or, if later, the date a particular sales incentive is offered, as required by ASC 605-50-45 because there is no identifiable benefit or evidence of fair value of the consideration given to customers. Additionally, slotting fees, temporary price reductions and cooperative advertising costs do not meet the separability aspects of ASC 605-50-45. We propose to enhance our financial statement accounting policy disclosure in future filings to describe the timing and location of amounts recorded as follows:

As is customary in the consumer products industry, we participate in promotional programs with our customers to enhance the sale of our products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution including slotting fees, and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. We recognize the cost of such sales incentives by recording an estimate of such cost as a reduction of revenue, at the later of (a) the date the related revenue is recognized, or (b) the date when a particular sales incentive is offered. At the completion of the promotional program, these estimated amounts are adjusted to actual amounts.

Read in the reply
In its next report

First report after the company's reply of Mar 12, 2013: 10-K filed May 17, 2013 ↗, against the 10-K filed May 18, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 3. Acquisitions · Acquisition of GlaxoSmithKline OTC Brands, page 64
SEC asked (2)
Please tell us what consideration was given to identifying other identifiable intangible assets such as customer lists or relationships, customer contracts, contract-based intangibles such as a license, and technology-based intangibles such as unpatented technology. Refer to the guidance in ASC 805-20-55-11 through 805-20-55-57.
Rest of the question

In addition, please tell us what specific characteristics or other specific facts and circumstances where considered when determining whether an intangible had an indefinite or a finite life.

PBH answered
Through two separate business combination transactions, on January 31, 2012 and March 30, 2012, the Company acquired 17 over-the-counter healthcare (“OTC”) brands from GlaxoSmithKline plc (“GSK”). These transactions were structured as acquisitions of assets, and were limited to inventory and the trademarks associated with the brands.

As part of the identification of the assets acquired, we considered whether any additional intangible assets were acquired in the transactions, including those cited in ASC 805-20-55-11 through 805-20-55-57.
Rest of the answer

We believe the only material intangible assets acquired are the brands themselves, as represented by the brand trademarks. These OTC remedies have been available to consumers for decades, and there are no associated pharmaceutical patents or other significant patented or unpatented technology. Further, we continue to procure product contracted by third party manufacturers and we did not acquire or license any specific know-how or technology relating to the manufacturing of products. Therefore, no additional intangible assets or technology-based intangible assets were identified as part of the brands acquired in the transactions.

The customers associated with the brands (who act, in turn, as distributors to end-use consumers) include mass merchandisers, food and drug stores, and dollar and club stores located primarily in the U.S. However, based upon our experience, we do not regard the relationships between these retail customers and the entity managing the brand as representing significant intangible assets acquired in the transactions, but rather we ascribe significant value to the relationship with the brand, which is the primary driver of the value. Specifically, since the brands represent enduring personal products, which are sought out by loyal end-use consumers, the successful sale of these products is dependent on the brands' connection with the end-consumer, rather than with the brand manager's development of a distribution channel. Further, we did not acquire any specific distribution rights or customer lists in connection with this acquisition.

The factors considered in evaluating whether the brands were of an indefinite or a finite life included category trends, the age of the brands, their historical and projected performance, our expected investment to support the particular brand, their market share and position compared to competing brands, and their expectation for future growth. Acquired brands which have been assigned an indefinite life include those which have held a commercial presence for decades, and are among the leaders in market share. The enduring nature of these brand names is demonstrated by their continued use under different previous owners. A finite life has been assigned to the minor brands with more moderate growth prospects and less recognition in the marketplace.

Read in the reply
In its next report

First report after the company's reply of Mar 12, 2013: 10-K filed May 17, 2013 ↗, against the 10-K filed May 18, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 21. Condensed Consolidating Financial Statements, page 88
SEC asked (3)
You state that a significant portion of your operating income and cash flow is generated by your subsidiaries. As a result, funds necessary to meet Prestige Brands, Inc.'s debt service obligations are provided in part by distributions or advances from the Company's subsidiaries.
Rest of the question

Under certain circumstances, contractual and legal restrictions, as well as the financial condition and operating requirements of the Company's subsidiaries, could limit Prestige Brands, Inc.'s ability to obtain cash from your subsidiaries for the purpose of meeting its debt service obligations, including the payment of principal and interest on the Senior Notes. Your disclosure in Note 10 indicates there are no significant restrictions at the subsidiary level of the guarantors, but it is not clear if there are any restrictions at the guarantor level. Please provide proposed disclosure to be included in future filings to disclose the amounts of restricted net assets for subsidiaries and/or guarantor subsidiaries as of the end of the most recently completed fiscal year or tell us how your disclosure complies with Rule 3-10(i)(10) and Rule 4-08(e)(3)(ii) of Regulation S-X.

PBH answered
The Company believes that the disclosure provided in Notes 10 and 21 satisfy the disclosure requirements of Rule 3-10(i)(10) of Regulation S-X, including the requirements of Rule 4-08(e)(3)(ii). Rule 4-08(e)(3) of Regulation S-X requires, generally, the disclosure of (i) the nature of any restrictions on the ability of subsidiaries to transfer funds to the registrant in the form of cash dividends, loans or advances and (ii) the amounts of such restricted net assets for subsidiaries as of the end of the most recent fiscal year.

Note 10 states that there are no significant restrictions on the
Rest of the answer

ability of any of the guarantors to obtain funds from their subsidiaries, In addition, the disclosure in Note 21 discusses that the Company and guarantors are subject to certain covenants under a credit agreement for each of the Term Loan Facility and the ABL Facility and an indenture for each of the 2018 Notes and the 2020 Notes. Under these covenants, the Company and guarantors are subject to limitations on the incurrence of additional indebtedness, payment of dividends and the incurrence of liens; however, neither the credit agreements nor the indentures contain restrictions on the ability of the guarantors to pay dividends or make payments to the Company or to Prestige Brands, Inc., the issuer, except those imposed by law or other routine limitations. Accordingly, the Company believes it has provided the required disclosure.

However, we propose to clarify in future filings that there are no significant restrictions on the ability of any of the guarantors to make payments to Prestige Brands, Inc., the issuer, or the Company or to obtain funds from their subsidiaries.

Read in the reply
In its next report

First report after the company's reply of Mar 12, 2013: 10-K filed May 17, 2013 ↗, against the 10-K filed May 18, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Form 10-Q for the nine months ended December 31, 2012 · Note 10. Long Term Debt, page 13
SEC asked (4)
You state that the amounts of the accelerated amortization were not material to the consolidated financial statements for the quarters ended June 30, 2012, September 30, 2012, and December 31, 2012 and the cumulative amount of the adjustment is not material to the estimated results of operations for the year ended March 31, 2013 yet the cumulative amount appears to understate both pre-tax and after tax net income
Rest of the question

for the three months ended December 31, 2012 by 15%. Please tell us how you determined that these amounts are not material to the quarter ended December 31, 2012 and therefore you are not required to revise the quarterly periods ended June 30, 2012 and September 30, 2012.

PBH answered
We performed a contemporaneous analysis to evaluate the quantitative and qualitative impact of the accelerated amortization recorded and disclosed as an out-of-period adjustment in the quarter ended December 31, 2012. Management did not rely on any one particular quantitative or qualitative factor and instead considered all relevant information in evaluating whether the amounts referenced should be considered material in accordance with ASC 250-10-45-27.

The following table summarizes the period of origination of the errors and the quantitative impact of the out-of-period adjustment:

FY'12
Rest of the answer

YTD

FY'13-Q1

FY'13-Q2

FY'13-Q3

FY'13 YTD

Amortization

$

(1,089

)

(1,220

(740

3,049

1,089

Income before income taxes (as reported)

61,157

23,985

31,496

20,061

75,542

% impact

(2

)%

(5

%

We considered the impact of the above out-of-period adjustments in relation to the periods in which the errors originated. Accordingly, we concluded that the portion of the error originating in fiscal 2012 is not material to our fiscal 2013 year to date results or to the expected results for the year ending March 31, 2013. We also considered that the impact of the errors was not significant to any of the interim periods in which the errors originated.

In performing the quantitative and qualitative evaluation, management relied on the following authoritative guidance:

•

ASC 250-10-S99-1, Securities and Exchange Commission SAB Topic 1M, formerly Staff Accounting Bulletin 99, “Materiality”

ASC 250-10-S99-2, Securities and Exchange Commission SAB Topic 1N, formerly Staff Accounting Bulletin 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”

ASC 250-10-05, formerly Financial Accounting Standards Statement Number 154, “Accounting Changes and Error Corrections - A Replacement of APB Opinion No. 20 and FAS Statement No. 3”

We also note that even though the cumulative adjustment amount understates both reported pre-tax income and reported net income by 15% (13% on an adjusted basis) in the quarter ended December 31, 2012, these amounts are non-cash, and the write-off was triggered by continued positive cash flow of the Company allowing us to make additional voluntary payments on our debt. We also considered the following additional qualitative considerations:

The adjustment was a non-cash charge to interest expense.

The adjustment did not materially affect a trend in earnings or earnings growth, and had no affect on income from operations. There was no impact to segment reporting and the item would not change income to a loss or vice-versa.

We believe that investors typically do not focus on non-cash related charges in their expectations.

We also believe that analysts following our Company focus more on the operating performance of the brands rather than the non-cash charges recorded on our debt, especially when exhibiting strong cash flow performance. Additionally, we would not have failed to meet or beat analysts' expectations if such amounts were recorded in the prior periods.

There was no significant change to our debt covenants. The Company would have clearly passed both before and after the slight adjustment to the interest coverage covenant.

Based on all of the relevant information, including the above qualitative considerations, as more fully outlined in our materiality memorandum provided supplementally to the Staff, management concluded that the preponderance of information supported our conclusion that the adjustments were not material to any period including the quarter ended December 31, 2012.

Our materiality memorandum is being provided to the Staff under separate cover by counsel to the Registrant on a confidential and supplemental basis pursuant to Rule 12b-4 under the Exchange Act of 1934, as amended. In accordance with Rule 12b-4, the Registrant requests that these materials be returned to the Registrant promptly following completion of the Staff's review thereof. By separate letter, counsel to the Registrant also has requested confidential treatment of these materials pursuant to 17 C.F.R. § 200.83.

Read in the reply
In its next report

First report after the company's reply of Mar 12, 2013: 10-K filed May 17, 2013 ↗, against the 10-K filed May 18, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 21. Condensed Consolidating Financial Statements, page 25
SEC asked (5)
You state on page 34 that you determined in the first quarter of 2013 that certain amounts in the condensed consolidated financial statements have been incorrectly stated. You also state that you will disclose the impact of the revisions on previously reported amounts and accordingly revise the Condensed Consolidated Financial Statements for comparative periods in your future filings.
Rest of the question

As the revisions appear significant, please provide us your analysis as to why you do not believe you should amend to provide corrected information for all periods.

PBH answered
Management considered all relevant information in evaluating whether the amounts referenced should be considered material when evaluated in the context of the financial statements as a whole. We also considered that the misstatement did not negatively impact the presentation of the issuer's or guarantors' ability to make debt payments or significantly impact the results of the non-guarantor subsidiaries.
Rest of the answer

Additionally, there was no impact on the consolidated financial statements as the change in earnings for the issuer was eliminated in consolidation.

Contemporaneous with our identification of the error in the first quarter of 2013, we performed an analysis to evaluate the materiality of the error to the financial statements taken as a whole. We have subsequently updated our analysis as of the end of each period to support our conclusion that the error was immaterial. We have supplementally provided to the staff our materiality memorandum and analysis for the quarter ended June 30, 2012 for reference, which represents the first period that the condensed consolidated financial statements were revised.

Our conclusion that the error was immaterial was based, in part, on the following qualitative and quantitative considerations:

The adjustments increase net income and cash flows from operating activities of the subsidiary guarantor, thereby increasing the ability of the guarantor to pay dividends to the registrant in order to make payments against our debt.

The Company has a strong history of servicing all debt payments as evidenced by our accelerated prepayments of outstanding principal under certain of our debt facilities.

The non-guarantors represented less that 1% of the total assets of the Company before and after the revision. Accordingly, the adjustment had an insignificant impact on our ability to service our debt by either the issuer or the guarantor. We believe that the readers of the guarantor footnote are most likely to focus on the consolidated financial statements in conjunction with the combined columns of the parent, the issuer and the combined subsidiary guarantors, given the insignificance of the non-guarantor column, and that there are no significant restrictions on the ability of the guarantors to make payments to the issuer or the Company to obtain funds from its subsidiaries, as explained in our response to comment #3.

In our experience, investors and creditors have focused on our ability to secure and service our debt rather than the financial position, earnings and cash flows of our guarantor subsidiaries.

Our materiality memorandum is being provided to the Staff under separate cover by counsel to the Registrant on a confidential and supplemental basis pursuant to Rule 12b-4 under the Exchange Act of 1934, as amended. In accordance with Rule 12b-4, the Registrant requests that these materials be returned to the Registrant promptly following completion of the Staff's review thereof. By separate letter, counsel to the Registrant also has requested confidential treatment of these materials pursuant to 17 C.F.R. § 200.83.

Based on the above analysis, including our materiality memorandum provided supplementally to the Staff, we concluded that the revision was not significant, and accordingly, we elected to present the corrected comparative information in our periodic filings as such periods arose (i.e., the quarters ended June 30, 2012, September 30, 2012 and December 31, 2012) rather than amending to provide corrected information for all periods.

The Registrant hereby acknowledges that:

¤ the Registrant is responsible for the adequacy and accuracy of the disclosure in the filings;

Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filings; and the Registrant may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We trust that this has been responsive to the Staff's comments. If there are additional questions or comments, please contact the undersigned at (914) 524-6806.

Read in the reply
In its next report

First report after the company's reply of Mar 12, 2013: 10-K filed May 17, 2013 ↗, against the 10-K filed May 18, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Form 10-Q for the nine months ended December 31, 2012 · Note 10. Long Term Debt, page 13
SEC asked (1)
We note your response to prior comment 4. Please revise your table in Appendix A to also include the quantitative impact of the errors on the quarterly period ended March 31, 2012 and an analysis to clarify whether the impacts are material to that quarter and the reasons why or why not.
PBH answered
We are updating our previous response to provide the quantitative impact of the errors on the quarterly period ended March 31, 2012. Although we did not specifically reference the fourth quarter of fiscal 2012 in the formal analysis presented, we had considered the impact in the fourth quarter, which we determined to be immaterial.

We have included in our analysis an evaluation of the quantitative and qualitative impact of the accelerated amortization on the fourth quarter of fiscal 2012.
Rest of the answer

Management did not rely on any one particular quantitative or qualitative factor and instead considered all relevant information in evaluating whether the amounts referenced should be considered material in accordance with ASC 250-10-45-27. We also considered the guidance in paragraph 29 of APB 28, in assessing materiality.

We note that the fourth quarter of fiscal 2012 included certain significant items that adversely impacted our fiscal 2012 fourth quarter results, which included charges to our earnings related to our acquisition of the acquired GSK brands as well as the loss on the extinguishment of debt. Due to these items, our reported results were close to break-even, which was not consistent with our trend of earnings. Accordingly, we considered these items when evaluating the materiality of the errors to the fourth quarter of fiscal 2012. When excluding such items, the impact of the accelerated amortization on income before income taxes was 5%. After considering the quantitative and qualitative impact in the context of FY'12-Q4 and full year fiscal 2012, we concluded that the impact was not material. Additionally, we considered the guidance in paragraph 29 of APB 28, and concluded that the originating error was not significant to the results for the quarter ended March 31, 2012.

The following table summarizes the quantitative impacts of the out-of-period adjustments on the fourth quarter and full year ended March 31, 2012:

(dollars in thousands)

Reported

Adjusted

Adjusted for below charges *

FY'12-Q4

FY'12 YTD

Amortization

(1,089

)

Income (loss) before income taxes

800

(289

20,382

61,157

60,068

% impact

(136

)%

377

%

(5

(2

* Our results for the fourth quarter ended March 31, 2012 were adversely affected by the presence of significantcharges that reduced income before income taxes by $20.7 million in that quarter, relating primarily to acquisition related charges, debt extinguishment charges and unsolicited proposal costs. Accordingly, removing the effect of these amounts, the impact of the change on income before income taxes for the fourth quarter of fiscal 2012 was 5%. These charges consist of the following items, which were highlighted in our earnings release for the fourth quarter ended March 31, 2012:

(In thousands)

Inventory step up charge associated with acquisitions

$

1,795

Legal and professional fees associated with acquisitions

8,142

Transition costs associated with GSK brands acquired

3,588

Unsolicited proposal costs

1,737

Loss on extinguishment of debt

5,409

Total adjustments to income before income taxes

20,671

Consistent with our conclusions in our response to prior comment 4, the qualitative factors impacting our year to date results for fiscal 2012 are also relevant to our fourth quarter as described below.

In performing the quantitative and qualitative evaluation, management relied on the following authoritative guidance:

•

ASC 250-10-S99-1, Securities and Exchange Commission SAB Topic 1M, formerly Staff Accounting Bulletin 99, “Materiality”

ASC 250-10-S99-2, Securities and Exchange Commission SAB Topic 1N, formerly Staff Accounting Bulletin 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”

ASC 250-10-05, formerly Financial Accounting Standards Statement Number 154, “Accounting Changes and Error Corrections - A Replacement of APB Opinion No. 20 and FAS Statement No. 3”

We also note that the amount related to the quarter ended March 31, 2012 is non-cash, and the write-off was triggered by continued positive cash flow of the Company allowing us to make additional voluntary payments on our debt. We also considered the following additional qualitative considerations:

The error was a non-cash charge to interest expense.

The error did not materially affect a trend in earnings or earnings growth, and had no effect on income from operations. There was no impact to segment reporting and the item would not change income to a loss or vice-versa, except for FY'12-Q4, which would occur only due to the significant charges detailed above that occurred in the fourth quarter. Absent these significant charges, our results are more consistent and comparable with our prior earnings trends.

We believe that investors typically do not focus as much on non-cash related charges in their expectations, and that this error would not impact our earnings trends.

We also believe that analysts following our Company focus more on the operating performance of the brands rather than the non-cash charges recorded on our debt, especially when exhibiting strong cash flow performance. Additionally, we would not have failed to meet or beat analysts' expectations if such amounts were recorded in the prior periods. The impact of this error was 5% after removing the significant charges described above.

There was no significant change to our debt covenants. The Company would have clearly passed both before and after the slight adjustment to the interest coverage covenant.

Based on all of the relevant information, including the above qualitative considerations, and as outlined in our updated materiality memorandum provided supplementally to the Staff, management concluded that the preponderance of information supported our conclusion that the error was not material to the fourth quarter ended March 31, 2012.

As requested by the Staff, we have updated our materiality memorandum to include the fourth quarter of fiscal 2012. Our updated materiality memorandum is being provided to the Staff under separate cover by counsel to the Registrant on a confidential and supplemental basis pursuant to Rule 12b-4 under the Exchange Act of 1934, as amended. In accordance with Rule 12b-4, the Registrant requests that these materials be returned to the Registrant promptly following completion of the Staff's review thereof. By separate letter, counsel to the Registrant also has requested confidential treatment of these materials pursuant to 17 C.F.R. § 200.83.

Read in the reply
In its next report

First report after the company's reply of Apr 24, 2013: 10-K filed May 17, 2013 ↗, against the 10-K filed May 18, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 21. Condensed Consolidating Financial Statements, page 25
SEC asked (2)
We note your response to prior comment 5. Please address the following:  On page 13 you reference 100% owned subsidiaries but in Note 21, you refer to whollyowned subsidiaries. Please confirm that the issuer subsidiary and the guarantor subsidiaries referred to in Note 21 are 100% owned and, if so, revise your disclosure in future filings to clarify this information.
Rest of the question

 Please provide us additional materiality quantification analyses for the fiscal years ended March 31, 2011 and March 31, 2012 and the quarterly periods ended June 30, 2012 and September 30, 2012  Please tell us what annual and quarterly interim and year to date periods contain errors for which you proposed not to include corrected condensed consolidated financial information in future filings.

PBH answered
We have included our responses to the Staff's comment in each of the following bullets, which appear in the same order of the bullet requests above.

We confirm that the issuer subsidiary and the guarantor subsidiaries referred to in Note 21 are 100% owned and that we will revise our disclosure in future filings to clarify this information.

Although we did not include these periods in the formal analysis presented, we did consider and evaluate the effects on these periods when we performed our analysis.
Rest of the answer

In response to the Staff's comment, we have updated our analysis for all periods, and we are supplementally providing to the Staff our memorandum with the additional materiality quantification analyses for the fiscal years ended March 31, 2011 and March

31, 2012 and the quarterly period ended June 30, 2012. Our conclusions for these periods are consistent with our previous conclusions that the error was immaterial. As noted in our memorandum, we also updated our analysis during the quarter ended September 30, 2012 to reflect minor additional adjustments related to the quarter ended June 30, 2012 that we identified during the September 30, 2012 close process. Accordingly, we properly reflected all adjustments and revisions in our Form 10-Q filing for the quarter ended September 30, 2012.

We plan to revise the condensed consolidating financial statements for all periods affected, except the year ended March 31, 2010 and the three months ended June 30, 2011. As noted in the materiality memorandum provided supplementally to the Staff, we identified additional minor adjustments during the quarter ended September 30, 2012, which related to the quarter ended June 30, 2012. These adjustments were reflected in our Form 10-Q for the quarter ended September 30, 2012, but had not been included in the previously reported condensed consolidating financial statements for the quarter ended June 30, 2012 or the previously revised condensed consolidating financial statements for the comparative quarter ended 2011. Accordingly, we will revise the condensed consolidating financial statements for the quarter ended June 30, 2012 when we file our Form 10-Q for the quarter ended June 30, 2013. Our quantitative analysis of these additional adjustments for the quarter ended June 30, 2012 is included in our materiality memorandum being provided supplementally to the Staff. We have concluded that the revisions are not material to any of the periods, and we do not plan to revise the year ended March 31, 2010 or the quarter ended June 30, 2011, based on the quantitative and qualitative analyses below. We also believe that the corrections are not currently useful to an investor as more current information is available and the trends are consistent with our previous analysis and disclosures.

Consistent with our analysis previously submitted, management considered all relevant information in evaluating whether the amounts referenced should be considered material when evaluated in the context of the financial statements as a whole for the fiscal years ended March 31, 2011 and March 31, 2012. We also considered that the misstatement did not negatively impact the presentation of the issuer's or guarantors' ability to make debt payments or significantly impact the results of the non-guarantor subsidiaries. Additionally, there was no impact on the consolidated financial statements, as the change in earnings for the issuer was eliminated in consolidation.

Contemporaneous with our identification of the error in the first quarter of fiscal 2013, we performed an analysis to evaluate the materiality of the error to the financial statements taken as a whole. We are supplementally providing to the Staff our materiality memorandum and analysis for the quarters ended June 30, 2012 and September 30, 2012 and for the years ended March 31, 2011 and 2012 for reference. We have previously provided the Staff with our initial materiality memorandum and analysis for the quarter ended June 30, 2012, which represents the first period that the condensed consolidated financial statements were revised.

Our conclusion that the error was immaterial for all prior periods was based, in part, on the following qualitative and quantitative considerations:

The adjustments increase net income and cash flows from operating activities of the subsidiary guarantor, thereby increasing the ability of the guarantor to pay dividends to the registrant in order to make payments against our debt.

The Company has a strong history of servicing all debt payments as evidenced by our accelerated prepayments of outstanding principal under certain of our debt facilities.

The non-guarantors represented less than 1% of the total assets of the Company before and after the revision. Accordingly, the adjustment had an insignificant impact on our ability to service our debt by either the issuer or the guarantor. We believe that the readers of the guarantor footnote are most likely to focus on the consolidated financial statements in conjunction with the combined columns of the parent, the issuer and the combined subsidiary guarantors, given the insignificance of the non-guarantor column, and that there are no significant restrictions on the ability of the guarantors to make payments to the issuer or the Company to obtain funds from its subsidiaries.

In our experience, investors and creditors have focused on our ability to secure and service our debt rather than the financial position, earnings and cash flows of our guarantor subsidiaries.

Our materiality memorandum has been updated for the years ended March 31, 2011 and 2012 and the first and second quarters of fiscal 2013 and is being provided to the Staff under separate cover by counsel to the Registrant on a confidential and supplemental basis pursuant to Rule 12b-4 under the Exchange Act of 1934, as amended. In accordance with Rule 12b-4, the Registrant requests that these materials be returned to the Registrant promptly following completion of the Staff's review thereof. By separate letter, counsel to the Registrant also has requested confidential treatment of these materials pursuant to 17 C.F.R. § 200.83.

Based on the above analysis, including our materiality memorandum provided supplementally to the Staff, we concluded that the revision was not significant, and accordingly, we decided to present the corrected comparative information in our periodic filings as such periods arose (i.e., the quarters ended June 30, 2012, September 30, 2012, December 31, 2012 and March 31, 2013), rather than amending to provide corrected information for all periods.

The Registrant hereby acknowledges that:

¤ the Registrant is responsible for the adequacy and accuracy of the disclosure in the filings;

Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filings; and the Registrant may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We trust that this has been responsive to the Staff's comments. If there are additional questions or comments, please contact the undersigned at (914) 524-6806.

Read in the reply
In its next report

First report after the company's reply of Apr 24, 2013: 10-K filed May 17, 2013 ↗, against the 10-K filed May 18, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2013-05-06

Form S-4

2012-07-09 to 2012-07-09 · 1 question · 1 letter from the SEC, 0 from the company
No closing letter
SEC letter of Jul 9, 2012 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
SEC asked
We note that you are registering the 8.25% Senior Notes due 2020 (the “exchange notes”) in reliance on our position enunciated in Exxon Capital Holdings Corp., SEC No-Action Letter (April 13, 1998). See also Morgan Stanley & Co. Inc., SEC No- Action Letter (June 5, 1991) and Shearman & Sterling, SEC No-Action Letter (July 2, 1993).
Rest of the question

Accordingly, with the next amendment, please provide us with a supplemental letter stating that you are registering the exchange offer in reliance on our position contained in these letters and include the representations contained in the Morgan Stanley and Shearman & Sterling no-action letters.

PBH answered

No reply letter found.

Schedule 14A

2012-05-08 to 2012-05-18 · 5 questions · 1 letter from the SEC, 1 from the company
No closing letter
Acquisitions
Schedule 14A · Who is soliciting my vote, page 2
SEC asked (1)
We note that proxies may be solicited personally or by mail or telephone. Please be advised that all written soliciting materials, including any scripts to be used in soliciting proxies over the telephone or any e-mail correspondence and any information posted on the Internet must be filed under the cover of Schedule 14A. Refer to Rule 14a-6(b) and (c).
PBH answered
The Company acknowledges that it is mindful of Rule 14a-6(b) and (c) and confirms its understanding that all written soliciting materials, including any scripts to be used in soliciting proxies over the telephone or any e-mail correspondence and any information posted on the Internet, must be filed under the cover of Schedule 14A.
Read in the reply
Genomma’s Unsolicited, Non-binding Proposal and Proxy Solicitation, page 9 · Genomma’s Unsolicited, Non-Binding Proposal, page 9
SEC asked (2)
Please revise to update the discussion given that Genomma has decided not to pursue the acquisition proposal.
PBH answered
The Company has revised this section to reflect the fact that Genomma has decided not to pursue the acquisition proposal. In addition, the

Company has made appropriate modifications to the Schedule 14A to reflect Genomma’s withdrawal of its director nominees and stockholder proposal. Please refer to the changed pages of the revised Schedule 14A attached hereto as Exhibit A.
Read in the reply
Genomma’s Unsolicited, Non-binding Proposal and Proxy Solicitation, page 9 · Genomma’s Unsolicited, Non-Binding Proposal, page 9
SEC asked (3)
Please revise to include a background discussion of the contacts between the participants and the issuer during the time leading up to the current proxy solicitation. Please also describe how the Board or management responded to contacts made by the participants and the material details of any discussions or correspondence.
PBH answered
In response to this comment, the Company has revised the Schedule 14A to include a background discussion of the contacts between Genomma and the Company during the time leading up to the current proxy solicitation and how the Board or management responded to contacts made by Genomma and the material details of discussions and correspondence.
Rest of the answer

Specifically, the Company has added additional disclosure regarding contacts between Genomma and its financial advisors and the Company and its financial advisors that have occurred since the filing of the Schedule 14A relating to, among other things, Genomma’s withdrawn proposal to acquire the Company.

Please refer to the changed pages of the revised Schedule 14A attached hereto as Exhibit A for the text of such revisions.

Read in the reply
Proposal 4- Genomma’s Bylaw Amendment Repeal Proposal, page 22 · What does the Board recommend, page 22
SEC asked (4)
Please revise to further describe how the Bylaw Amendment Proposal violates Delaware law and specifically how it conflicts with the Amended and Restated Certificate of Incorporation.
PBH answered
As Genomma has withdrawn the Bylaw Amendment Repeal Proposal, the Company has revised the Schedule 14A to delete all relevant sections discussing the Bylaw Amendment Repeal Proposal. Please refer to the changed pages of the revised Schedule 14A attached hereto as Exhibit

A for the text of such revisions.
Read in the reply
Proxy Card
SEC asked (5)
Please clearly mark the form of proxy as a “preliminary” copy as required by Rule 14a6(e)(1).
PBH answered
As a result of Genomma’s decision to withdraw its director nominations and other stockholder proposal, the only matters to be acted upon at the Annual Meeting are now within the categories set forth in Rule 14a-6(a)(1)-(8). Accordingly, the Company intends to only file a definitive proxy statement and form of proxy with the Commission.

In connection with the responses provided herein and the Schedule 14A, the Company has directed us to acknowledge on its behalf that:

· the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

· staff comments or changes to
Rest of the answer

disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply

Form 10-K

2012-02-17 to 2012-03-30 · 8 questions · 2 letters from the SEC, 1 from the company
Review closed 2012-03-30
RevenueSegmentsGoodwill and impairmentAcquisitionsCritical estimatesLegal and contingencies
Critical Accounting Policies and Estimates · Valuation of Intangible Assets and Goodwill, page 33
SEC asked (1)
You indicate the brands that comprise the majority of intangible assets, primarily trademarks with indefinite lives, at March 31, 2011. Intangible assets represent 82% of pro forma total assets and 281% of pro forma stockholders’ equity reported in your Form 8-K filed on January 18, 2012.
Rest of the question

Considering the significance of intangible assets and acquisitions that have occurred during fiscal 2012, we believe you should disaggregate total intangible assets in the same manner in which you disclose revenue by product, as required by ASC 280-1050-40. Provide us proposed disclosure to be included in future periodic reports.

PBH answered
Considering the significance of the intangible assets and the acquisitions that have occurred during fiscal 2012, we will revise our disclosures in future filings to disaggregate total intangible assets in the same manner in which we disclose revenue for each group of similar products as required by ASC 280-10-50-40.
Rest of the answer

Below are the disclosures we propose to make in future filings in the Critical Accounting Policies and Estimates section of Management’s Discussion and Analysis of Financial Condition and Results of Operations, based on the Company’s Form 10-K for the fiscal year ended March 31, 2011:

March 31, 2011

March 31, 2010

(In thousands)

Over-the-

Counter

Healthcare

Household

Cleaning

Consolidated

Household Cleaning

Indefinite Lived:

Cough & Cold

$

185,453

—

88,843

GI

75,866

Eye & Ear Care

95,980

Dermatologicals

149,927

Oral Care

61,438

119,820

Total Indefinite Lived Intangible Assets

568,664

688,484

334,750

454,570

Finite Lived:

Read in the reply
In its next report

First report after the company's reply of Mar 16, 2012: 10-K filed May 18, 2012 ↗, against the 10-K filed May 13, 2011 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Notes to Consolidated Financial Statements · Note 18. Business Segments, page 77
SEC asked (2)
Provide us proposed disclosure to be included in future periodic reports of revenues for each product or each group of similar products as required by ASC 280-10-50-40. In your February 9, 2012 earnings presentation, you disaggregated revenue into analgesics, cough/cold, GI, eye & ear, dermatological, oral care and sleep aids.
PBH answered
In our February 9, 2012 earnings presentation, we disaggregated revenue into similar product groups as set forth in Comment 2 above. In future filings, we will combine our sleep aids into the other OTC brands and will not separately disclose sleep aids. Therefore, set forth below is our proposed disclosure in future filings for net revenues, based on the Company’s Form 10-K for the fiscal year ended March 31, 2011.

Year Ended March 31,
Read in the reply
In its next report

First report after the company's reply of Mar 16, 2012: 10-K filed May 18, 2012 ↗, against the 10-K filed May 13, 2011 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 20. Gain on Settlement, page 24
SEC asked (3)
Specify the nature of the litigation matter in proposed disclosure to be included in future periodic reports. Tell us when the costs netted against the payment received were incurred and why the costs were not required to be charged to expense when incurred if incurred prior to the quarter ended June 30, 2011.
PBH answered
The specific nature of the litigation was a legal malpractice and breach of contract action the Registrant brought against a law firm that previously represented the Registrant. We note the Staff’s comment and we propose to include the following disclosure in future periodic reports:

On June 15, 2011, we received a settlement payment of $8.0 million in the resolution of pending litigation, which Prestige Brands, Inc.
Rest of the answer

had initiated for legal malpractice, breach of contract and breach of fiduciary duty against a law firm and two individual lawyers who had previously provided legal representation to Prestige Brands, Inc.

Because the result of the litigation could only have resulted in a potential gain and the amount could not be determined prior to the settlement, the settlement payment was not disclosed prior to the actual receipt of the settlement. Additionally, the costs netted against the gain during the period ended June 30, 2011 were legal fees paid solely on a contingent basis and other immaterial legal fees incurred in the period ended June 30, 2011. All other costs and legal fees that were incurred prior to the period ended June 30, 2011 were immaterial and expensed as incurred.

Read in the reply
In its next report

First report after the company's reply of Mar 16, 2012: 10-K filed May 18, 2012 ↗, against the 10-K filed May 13, 2011 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Revenues, page 37
SEC asked (4)
You disclose for the nine months ended December 31, 2011 for the OTC Healthcare Segment that “Revenue increases for Little Remedies, Clear Eyes and The Doctor's were partially offset by revenue decreases in our other OTC Healthcare brands.” Provide us proposed disclosure to be included in future periodic reports that quantifies the amount of the revenue increase and decrease for each product or group of similar
Rest of the question

products and period presented.

PBH answered
Historically, we have disclosed that in our OTC Healthcare segment we have five brands that we consider to be core brands, which were comprised of Chloraseptic, Clear Eyes, Compound W, Little Remedies and The Doctor’s. We have included these five brands in all periods presented, and we have historically disclosed the increase or decrease by segment and provided further explanation of significant increases or decreases from a particular product or product group to be more transparent to the reader.

However, because we did not consider the increases or decreases from a particular product
Rest of the answer

during the nine months ended December 31, 2011 to be significant, we did not disclose the increases and decreases by product. For clarification, while the OTC Healthcare segment net revenues increased $72.2 million for the nine months ended December 31, 2011 compared to the nine months ended December 31, 2010, $68.7 million was due to the acquisition of Blacksmith Brands and the Dramamine brand. The remaining $3.5 million increase in net revenues was comprised of higher net revenues for Little Remedies of $3.5 million, Clear Eyes of $1.6 million and The Doctor’s of $1.5 million. These increases were partially offset by revenue declines in our other OTC brands of $3.1 million, which included revenue declines of Compound W and Chloraseptic of less than $0.1 million each.

Considering the significance of the acquisition of 15 OTC brands from GlaxoSmithKline that we completed on January 31, 2012, in our future filings we will disaggregate the net revenues for our brands into groups of similar products. These product groups are set forth below in our proposed disclosure for future filings, based on the Company’s Form 10-Q for the quarter ended December 31, 2011.

The proposed format of the table below will quantify the performance of each group of products in our future filings.

Nine Months Ended December 31,

Increase

Net Revenues

%

2010

(Decrease)

1,954

0.6

2,293

1.0

(339

)

(14.8

)%

89,859

29.3

52,024

21.7

37,835

72.7

13,924

4.5

53,940

17.6

52,530

21.9

1,410

2.7

39,061

12.7

39,295

16.4

(234

(0.6

33,711

11.0

13,964

5.8

19,747

141.4

2,815

0.9

2,914

1.2

(99

(3.4

Total OTC Revenues

235,264

76.6

163,020

67.9

72,244

44.3

71,825

23.4

77,127

32.1

(5,302

(6.9

Read in the reply
Gross Profit, page 38
SEC asked (5)
You disclose for the nine months ended December 31, 2011 that gross profit for your legacy OTC Healthcare brands increased by $4.3 million. Provide us proposed disclosure to be included in future periodic reports that describes and quantifies each factor attributable to this increase.
PBH answered
We note that the disclosure of the $4.3 million increase relates to the three months ended December 31, 2011, rather than the nine months ended December 31, 2011. In response to the Staff’s comment, we propose to include the following disclosure in future filings, based on the Company’s Form 10-Q for the quarter ended December 31, 2011:

Gross profit for the OTC Healthcare segment increased $12.9 million, or 35.3%, during the three months ended December 31, 2011 versus the three months ended December 31, 2010.
Rest of the answer

The gross profit increase of $12.9 million for the OTC Healthcare segment was primarily the result of the additional gross profit related to the acquired Blacksmith Brands and Dramamine brand, which together added $8.6 million of gross profit. The remaining increase of $4.3 million was primarily due to an inventory adjustment charge of $3.5 million related to the Blacksmith Brands acquisition that was included in the three months ended December 31, 2010 and to a lesser extent, higher gross profit of $0.8 million from our Legacy Core OTC brands.

The Registrant hereby acknowledges that:

§ the Registrant is responsible for the adequacy and accuracy of the disclosure in the filings;

Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filings; and the Registrant may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We trust that this has been responsive to the Staff’s comments. If there are additional questions or comments, please contact the undersigned at (914) 524-6806.

Read in the reply
In its next report

First report after the company's reply of Mar 16, 2012: 10-K filed May 18, 2012 ↗, against the 10-K filed May 13, 2011 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

SEC letter of Mar 19, 2012 ↗ no reply letter on EDGAR
Soliciting Material filed under Rule 14a-12
SEC asked (1)
In future filings, please revise the cover page of the Schedule 14A to include the nominees as participants in the solicitation.
PBH answered

No reply letter found.

In its next report

First report after the SEC's letter of Mar 19, 2012: 10-K filed May 18, 2012 ↗, against the 10-K filed May 13, 2011 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Soliciting Material filed under Rule 14a-12
SEC asked (2)
We note you indicate that you “may” file a proxy statement and, in the process, this implies that the filing of a non-management definitive proxy statement is not a foregone conclusion. The Commission did not intend to create another exemption from the proxy rules when Rule 14a-12 was adopted.
Rest of the question

Parties intending to rely upon Rule 14a-12 in making proxy solicitations may only do so to the extent that they intend to file a proxy statement and solicit proxies. See interpretation I.D.3. in the July 2001 Interim Supplement to the Telephone Interpretations Manual publicly available on our website, www.sec.gov. Please confirm that the filing party will either (i) refrain from using such non-committal language in future communications by affirmatively stating its intention to file a definitive proxy statement; (ii) find an appropriate exemption under Rule 14a-2 from the application of Section 14(a) and Regulation 14A to future communications; or (iii) refrain from your public solicitation activities of Prestige Brands Holdings, Inc. security holders.

PBH answered

No reply letter found.

In its next report

First report after the SEC's letter of Mar 19, 2012: 10-K filed May 18, 2012 ↗, against the 10-K filed May 13, 2011 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Soliciting Material filed under Rule 14a-12
SEC asked (3)
We note you indicate that a description of direct and indirect interests will be contained in disclosure documents to be filed later. Please note that although participants relying upon Rule 14a-12 may refer to participant information provided in another filed document, the information must be available, current, and on file for review by security holders at the time the Rule 14a-12 materials are made publicly
Rest of the question

available. Participants may not refer to participant information to be provided at some future time such as the proxy statement. Refer to Rule 14a-12(a)(1)(i) and Exchange Act Release No. 42055, October 22, 1999, at Section II.C.1.b. In future filings, please revise to describe any direct or indirect interests.

PBH answered

No reply letter found.

In its next report

First report after the SEC's letter of Mar 19, 2012: 10-K filed May 18, 2012 ↗, against the 10-K filed May 13, 2011 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2012-03-30

Form S-4

2011-07-26 to 2011-07-26 · 2 questions · 1 letter from the SEC, 0 from the company
No closing letter
SEC letter of Jul 26, 2011 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
General
SEC asked (1)
We note that you are registering the 8.25% Senior Notes due 2018 (the “exchange notes”) in reliance on our position enunciated in Exxon Capital Holdings Corp., SEC No-Action Letter (April 13, 1998). See also Morgan Stanley & Co. Inc., SEC No- Action Letter (June 5, 1991) and Shearman & Sterling, SEC No-Action Letter (July 2, 1993).
Rest of the question

Accordingly, with the next amendment, please provide us with a supplemental letter stating that you are registering the exchange offer in reliance on our position contained in these letters and include the representations contained in the Morgan Stanley and Shearman & Sterling no-action letters.

PBH answered

No reply letter found.

Legal Opinion
SEC asked (2)
We note that in the legal opinion, the firm has assumed “the due authorization, execution and delivery of the Indenture and the Exchange Notes, including the guarantee of each of the Guarantors set forth therein, by each of the parties thereto under the laws of their respective jurisdictions of incorporation or organization.” While such an assumption is acceptable with respect to the Exchange Notes which have not
Rest of the question

yet been executed, the assumption is not acceptable with respect to the Indenture which has already been executed and the due authorization, execution and delivery of the Indenture are facts which may be verified and need not be assumed. Please revise the legal opinion to remove this assumption with respect to the Indenture.

PBH answered

No reply letter found.

Form S-4

2010-08-10 to 2010-08-16 · 1 question · 1 letter from the SEC, 2 from the company
No closing letter
General
SEC asked
We note that you are registering the 8.25% Senior Notes due 2018 in reliance on our position enunciated in Exxon Capital Holdings Corp., SEC No-Action Letter (April 13, 1988). See also Morgan Stanley & Co. Inc., SEC No-Action Letter (June 5, 1991) and Shearman & Sterling, SEC No-Action Letter (July 2, 1993).
Rest of the question

Accordingly, with the next amendment, please provide us with a supplemental letter stating that you are registering the exchange offer in reliance on our position contained in these letters and include the representations contained in the Morgan Stanley and Shearman & Sterling no-action letters.

PBH answered
Prestige Brands, Inc. and the additional registrants listed on Schedule A to the Registration

Statement (together, the “Company”), each hereby request that the effective date for the

Registration Statement referred to above be accelerated so that it will be declared effective at

9:00 a.m. (ET) on Wednesday, August 18, 2010, or as soon as practicable thereafter, pursuant to

Rule 461 of the Securities Act of 1933, as amended.

The Company acknowledges that (i) should the Commission or the staff of the Commission, acting pursuant to delegated authority, declare the filing effective, such
Rest of the answer

declaration does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff of the Commission, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply

Also in this review: company letter, Aug 16, 2010

Form 10-K

2010-03-11 to 2010-05-11 · 5 questions · 1 letter from the SEC, 1 from the company
Review closed 2010-05-11
LeasesGoodwill and impairmentExecutive pay
Item I. Business · Intellectual Property, page 14
SEC asked (1)
Please expand this section to disclose all material patents, the products or technologies to which they relate, the related expiration dates and the jurisdictions that issued them. Provide the same information for material owned and inlicensed patents and indicate if the patents are owned or licensed.
PBH answered
No additional disclosure will be necessary as none of the patents owned or licensed by the Registrant and its subsidiaries is material to the Registrant on a consolidated basis. The Company will revise its disclosures accordingly in future filings.
Read in the reply
In its next report

First report after the company's reply of Apr 8, 2010: 10-K filed Jun 11, 2010 ↗, against the 10-K filed Jun 15, 2009 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Item 2. Properties, page 26
SEC asked (2)
We note your disclosure that one of your core competencies is, “Innovation and Product Development.” Please consider where these activities take place and whether your lease agreement for this facility is material to your company and should be filed as an exhibit. Please revise or advise accordingly.
PBH answered
Supplementally, we advise you that the activities related to product innovation and development take place at a number of locations, including those of our suppliers and other third-parties who assist us with those functions. To the extent that any of those activities take place at our corporate headquarters in Irvington,

New York, those activities could be readily re-located to another location without material, if any, interruption. Accordingly, we do not believe that the lease for our corporate headquarters is material to those activities or otherwise to the Registrant.

7.
Rest of the answer

Management’s Discussion and Analysis of Financial Condition and

Read in the reply
In its next report

First report after the company's reply of Apr 8, 2010: 10-K filed Jun 11, 2010 ↗, against the 10-K filed Jun 15, 2009 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Operations · Valuation of Intangible Assets and Goodwill, page34
SEC asked (3)
For reporting units in which the estimated fair value is not substantially in excess of the carrying amount and therefore are at risk of failing step one of the impairment test, please revise your disclosure to include the following: • The percentage by which fair value exceeded carrying value as of the date of the most recent test; • The amount of goodwill allocated to the reporting unit; • A description of the
Rest of the question

methods and key assumptions used and how the key assumptions were determined; and • A discussion of the degree of uncertainty associated with the key assumptions. The discussion regarding uncertainty should provide specifics to the extent possible (e.g., the valuation model assumes recovery from a business downturn within a defined period of time).

PBH answered
believe that the Registrant's current disclosures already adequately address the third and fourth bullet points above - key assumptions, how they were determined and the appropriate degree of uncertainty with respect to these assumptions. In addition to the disclosures already included in the

Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31,

2009, we will add in future filings disclosures similar to the following when the fair value of our reporting units does not substantially exceed carrying value.

Company reports Goodwill and Indefinite-Lived Intangible Assets
Rest of the answer

in three operating segments; Over-the-Counter Healthcare, Household Cleaning and Personal

Care. The Company identifies its reporting units in accordance with

FASB Accounting Standards Codification Subtopic 280-10. The carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies previously discussed. As a result, any material changes to these assumptions could require the Company to record additional impairment charges in the future.

Goodwill

Operating Segment

Percent by which Fair Value

Exceeded Carrying Value in Annual

Test

Over-the-Counter

Healthcare

$ 104,100,000

58.1%

Household

Cleaning

7,389,000

0.0%

Personal

Care

2,751,000

207.5%

Indefinite-Lived Intangible

Assets

Indefinite-Lived

Intangible Assets

$ 345,467,000

31.8%

154,709,000

6.6%

–

Schedule 14A

Compensation Discussion and

Analysis

Annual Cash Incentive Plan,

Read in the reply
In its next report

First report after the company's reply of Apr 8, 2010: 10-K filed Jun 11, 2010 ↗, against the 10-K filed Jun 15, 2009 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Compensation Discussion and Analysis · Annual Cash Incentive Plan, page 23
SEC asked (4)
We note that your annual incentive cash awards are made based on a number of performance factors. Regardless of whether such awards were actually made, you should discuss the minimum, target and maximum levels of company performance that were set, and the level of achievement of each target.
Rest of the question

Please provide draft disclosure for your next proxy statement that includes the minimum, target and maximum performance targets that you have set for 2010, how the extent of achievement will affect the bonuses ultimately awarded, and confirm that in your proxy statement you will include the actual extent of achievement of each performance objective.

PBH answered
Set forth below is a template of how we would propose making the requested disclosures in future filings:

awards under our 2010 Management Bonus Plan, we used a performance matrix comprised of varying levels for the Company’s net sales and EBITDA during

2010. In order for an employee to earn a minimum, target or maximum bonus under the 2010 Management Bonus Plan, our 2010 net sales and EBITDA would have been required to meet one of the performance levels set forth in the table below.

Performance

Level

(Percent of
Rest of the answer

Plan)

Net

Sales

EBITDA

Payout

Amount

Minimum

(95%)

Target

(100%)

Maximum

(105%)

Our 2010 net sales and EBITDA were $_____ and $_____, respectively, which resulted in our employees receiving a bonus payout in an amount equal to __% of their target bonus. The 2010 Management Bonus Plan payouts to our Named Executive

Officers are set forth in the “Non-Equity Incentive Plan Compensation” column of the Summary Compensation Table on page ___ of this Proxy

Statement.

Read in the reply
In its next report

First report after the company's reply of Apr 8, 2010: 10-K filed Jun 11, 2010 ↗, against the 10-K filed Jun 15, 2009 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Restricted Common Stock Awards, page 24
SEC asked (5)
We note that the 90% level of performance regarding net sales and EBITDA results in the vesting of 75% of stock awards based on a three year performance period. Similarly, please disclose the level of performance that must be achieved in order to attain the 100% and 150% vesting levels, respectively.
Rest of the question

Also, disclose the EBITDA and net sales targets and the number of shares for each NEO that relates to the minimum, target and maximum levels of performance. You should provide this information whether or not the net sales and EBITDA targets were met and whether awards vested and to what extent. * * * Please respond to these comments within 10 business days or tell us when you will provide us with a response. Please furnish a letter that keys your responses to our comments and provide the requested information. Detailed letters greatly facilitate our review. Please furnish the letter to us via EDGAR under the form type label CORRESP.

PBH answered
awards under our 2005 Long-Term Equity Incentive Plan, we used a performance matrix comprised of varying levels for the Company’s net sales and EBITDA during number of shares under awards having a 2010 performance period, our net sales and EBITDA would have been required to meet one of the performance levels set forth in the table below.

(90%) employees earning a number of shares equal to __% of their target awards.
Rest of the answer

The value of the number of shares earned by our Named

Executive Officers based on our 2010 performance is set forth in the “Equity

Incentive Plan Compensation” column of the Summary Compensation Table on page

___ of this Proxy Statement.

* *

*

Registrant hereby acknowledges that:

the

Registrant is responsible for the adequacy and accuracy of the disclosure in the filings;

staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filings; and

Registrant may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We trust that this has been responsive to the Commission's comments. If there are additional questions or comments, please contact the undersigned.

Thanking you in advance for your cooperation.

Read in the reply
In its next report

First report after the company's reply of Apr 8, 2010: 10-K filed Jun 11, 2010 ↗, against the 10-K filed Jun 15, 2009 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: request for more time, Mar 15, 2010, closing letter, 2010-05-11

Letters without questions

Other letters

UPLOAD and CORRESP
2 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 25 letters filed since 2010-03-15. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PBH/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.